Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Xilio Therapeutics

Biotech & Life Sciences · Waltham, United States · Founded 2016 · IPO 2021 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Revenue
$44M
Latest reported FY

Investors

14 investors on Xilio Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage
Atlas Venture
F-Prime
Series B+ 12 investors entered at this stage
SV Health Investors
MRL Ventures
RiverVest Venture Partners
Ipsen
Bay City Capital
Rock Springs Capital
Solasta Ventures
M Ventures
RA Capital Management
Takeda Ventures
Bain Capital Life Sciences
Deerfield

Global footprint

Where Xilio Therapeutics has talent and traffic

Web traffic by country
5.7K monthly visits
across markets
🇺🇸 United States73.7%
🇮🇳 India21.1%
🇨🇦 Canada5.3%
Top 3 markets shown

See Xilio Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo